Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibility.

Human immunodeficiency virus type 1 (HIV-1) protease plays a fundamental role in the maturation and life cycle of the retrovirus HIV-1, as it functions in regulating post-translational processing of the viral polyproteins gag and gag-pol; thus, it is a key target of AIDS antiviral therapy. Accessibility of substrate to the active site is mediated by two flaps, which must undergo a large conformational change from an open to a closed conformation during substrate binding and catalysis. The electron paramagnetic resonance (EPR) method of site-directed spin labeling (SDSL) with double electron-electron resonance (DEER) spectroscopy was utilized to monitor the conformations of the flaps in apo HIV-1 protease (HIV-1PR), subtypes B, C, and F, CRF01_A/E, and patient isolates V6 and MDR 769. The distance distribution profiles obtained from analysis of the dipolar modulated echo curves were reconstructed to yield a set of Gaussian-shaped populations, which provide an analysis of the flap conformations sampled. The relative percentages of each conformer population described as "tucked/curled", "closed", "semi-open", and "wide-open" were determined and compared for various constructs. The results and analyses show that sequence variations among subtypes, CRFs, and patient isolates of apo HIV-1PR alter the average flap conformation in a way that can be understood as inducing shifts in the relative populations, or conformational sampling, of the previously described four conformations for HIV-1PR.

[1]  C. Simmerling,et al.  Drug pressure selected mutations in HIV-1 protease alter flap conformations. , 2009, Journal of the American Chemical Society.

[2]  R M Stroud,et al.  Domain flexibility in retroviral proteases: structural implications for drug resistant mutations. , 1998, Biochemistry.

[3]  Comparing the accumulation of active- and nonactive-site mutations in the HIV-1 protease. , 2004 .

[4]  Viktor Hornak,et al.  HIV-1 protease flaps spontaneously open and reclose in molecular dynamics simulations. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[5]  B. Dunn,et al.  The contribution of naturally occurring polymorphisms in altering the biochemical and structural characteristics of HIV-1 subtype C protease. , 2008, Biochemistry.

[6]  B. Torbett,et al.  Conformational flexibility in the flap domains of ligand-free HIV protease. , 2007, Acta crystallographica. Section D, Biological crystallography.

[7]  G. Fanucci,et al.  Interflap distances in HIV-1 protease determined by pulsed EPR measurements. , 2007, Journal of the American Chemical Society.

[8]  Maureen M Goodenow,et al.  Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavir. , 2006, Biochemistry.

[9]  S. Kent,et al.  Dynamics of "flap" structures in three HIV-1 protease/inhibitor complexes probed by total chemical synthesis and pulse-EPR spectroscopy. , 2009, Journal of the American Chemical Society.

[10]  G. Jeschke,et al.  Dead-time free measurement of dipole-dipole interactions between electron spins. , 2000, Journal of magnetic resonance.

[11]  T. Merigan,et al.  HIV-1 protease variants from 100-fold drug resistant clinical isolates: expression, purification, and crystallization. , 2003, Protein expression and purification.

[12]  H. Zimmermann,et al.  DeerAnalysis2006—a comprehensive software package for analyzing pulsed ELDOR data , 2006 .

[13]  B. Moss,et al.  An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Simmerling,et al.  Solution structure of HIV-1 protease flaps probed by comparison of molecular dynamics simulation ensembles and EPR experiments. , 2008, Journal of the American Chemical Society.

[15]  A. Velázquez‐Campoy,et al.  Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes. , 2002, Biochemistry.

[16]  G. Jeschke,et al.  Distance measurements on spin-labelled biomacromolecules by pulsed electron paramagnetic resonance. , 2007, Physical chemistry chemical physics : PCCP.

[17]  W. Scott,et al.  Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance. , 2000, Structure.

[18]  High-resolution structure of unbound human immunodeficiency virus 1 subtype C protease: implications of flap dynamics and drug resistance. , 2008, Acta crystallographica. Section D, Biological crystallography.

[19]  Celia A Schiffer,et al.  Hydrophobic sliding: a possible mechanism for drug resistance in human immunodeficiency virus type 1 protease. , 2007, Structure.

[20]  G. Fanucci,et al.  Monitoring inhibitor-induced conformational population shifts in HIV-1 protease by pulsed EPR spectroscopy. , 2009, Biochemistry.

[21]  A Wlodawer,et al.  Inhibitors of HIV-1 protease: a major success of structure-assisted drug design. , 1998, Annual review of biophysics and biomolecular structure.

[22]  A. Wlodawer,et al.  Structural characterization of B and non-B subtypes of HIV-protease: insights into the natural susceptibility to drug resistance development. , 2007, Journal of molecular biology.

[23]  C. Schiffer,et al.  Structural Analysis of Human Immunodeficiency Virus Type 1 CRF01_AE Protease in Complex with the Substrate p1-p6 , 2008, Journal of Virology.